FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1986102787> ?p ?o ?g. }

• W1986102787 endingPage "2070" @default.
• W1986102787 startingPage "2061" @default.
• W1986102787 abstract "Vortioxetine has reduced depressive symptoms in adults with major depressive disorder (MDD) in multiple clinical trials. The aim of this study is to evaluate the efficacy, safety, and tolerability of vortioxetine 15 and 20 mg vs placebo in adults with MDD. Patients were randomized 1:1:1:1 to vortioxetine 15 mg, vortioxetine 20 mg, duloxetine 60 mg (active reference), or placebo. The primary efficacy endpoint was mean change in Montgomery–Åsberg Depression Rating Scale (MADRS) total score at week 8 (MMRM). Safety/tolerability assessments included physical examinations, vital signs, laboratory evaluations, electrocardiograms, adverse events (AEs), Columbia–Suicide Severity Rating Scale, Arizona Sexual Experiences Scale, and Discontinuation–Emergent Signs and Symptoms checklist. Six hundred and fourteen patients were randomized. Mean changes in MADRS scores were −12.83 (±0.834), −14.30 (±0.890), −15.57 (±0.880), and −16.90 (±0.884) for placebo, vortioxetine 15 mg (P = .224), vortioxetine 20 mg (P = .023), and duloxetine 60 mg (P < .001) (P vs placebo), respectively. AEs reported by ≥5 % of vortioxetine patients included nausea, headache, diarrhea, dizziness, dry mouth, constipation, vomiting, insomnia, fatigue, and upper respiratory infection. Treatment-emergent sexual dysfunction, suicidal ideation or behavior, and discontinuation symptoms were not significantly different between vortioxetine and placebo. Vortioxetine 20 mg significantly reduced MADRS total scores after 8 weeks of treatment. Both vortioxetine doses were well tolerated. ClinicalTrials.gov identifier NCT01153009; www.clinicaltrials.gov/ ." @default.
• W1986102787 created "2016-06-24" @default.
• W1986102787 creator A5024369212 @default.
• W1986102787 creator A5065881205 @default.
• W1986102787 creator A5068791484 @default.
• W1986102787 creator A5081426855 @default.
• W1986102787 creator A5089404250 @default.
• W1986102787 date "2015-01-11" @default.
• W1986102787 modified "2023-10-18" @default.
• W1986102787 title "A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD" @default.
• W1986102787 cites W1970755410 @default.
• W1986102787 cites W1976410377 @default.
• W1986102787 cites W1983176528 @default.
• W1986102787 cites W1987514922 @default.
• W1986102787 cites W1987560991 @default.
• W1986102787 cites W1993810702 @default.
• W1986102787 cites W2001782289 @default.
• W1986102787 cites W2011606125 @default.
• W1986102787 cites W2029732660 @default.
• W1986102787 cites W2036812642 @default.
• W1986102787 cites W2048026164 @default.
• W1986102787 cites W2054766240 @default.
• W1986102787 cites W2057880023 @default.
• W1986102787 cites W2058572593 @default.
• W1986102787 cites W2059274457 @default.
• W1986102787 cites W2061669920 @default.
• W1986102787 cites W2066283885 @default.
• W1986102787 cites W2089659183 @default.
• W1986102787 cites W2131823335 @default.
• W1986102787 cites W2132324173 @default.
• W1986102787 cites W2137044513 @default.
• W1986102787 cites W2148083007 @default.
• W1986102787 cites W2149402043 @default.
• W1986102787 cites W2159271064 @default.
• W1986102787 cites W2160070901 @default.
• W1986102787 cites W2164182651 @default.
• W1986102787 cites W845297282 @default.
• W1986102787 doi "https://doi.org/10.1007/s00213-014-3839-0" @default.
• W1986102787 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4432084" @default.
• W1986102787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25575488" @default.
• W1986102787 hasPublicationYear "2015" @default.
• W1986102787 type Work @default.
• W1986102787 sameAs 1986102787 @default.
• W1986102787 citedByCount "74" @default.
• W1986102787 countsByYear W19861027872015 @default.
• W1986102787 countsByYear W19861027872016 @default.
• W1986102787 countsByYear W19861027872017 @default.
• W1986102787 countsByYear W19861027872018 @default.
• W1986102787 countsByYear W19861027872019 @default.
• W1986102787 countsByYear W19861027872020 @default.
• W1986102787 countsByYear W19861027872021 @default.
• W1986102787 countsByYear W19861027872022 @default.
• W1986102787 countsByYear W19861027872023 @default.
• W1986102787 crossrefType "journal-article" @default.
• W1986102787 hasAuthorship W1986102787A5024369212 @default.
• W1986102787 hasAuthorship W1986102787A5065881205 @default.
• W1986102787 hasAuthorship W1986102787A5068791484 @default.
• W1986102787 hasAuthorship W1986102787A5081426855 @default.
• W1986102787 hasAuthorship W1986102787A5089404250 @default.
• W1986102787 hasBestOaLocation W19861027871 @default.
• W1986102787 hasConcept C118552586 @default.
• W1986102787 hasConcept C126322002 @default.
• W1986102787 hasConcept C142724271 @default.
• W1986102787 hasConcept C15744967 @default.
• W1986102787 hasConcept C170493617 @default.
• W1986102787 hasConcept C197934379 @default.
• W1986102787 hasConcept C204787440 @default.
• W1986102787 hasConcept C27081682 @default.
• W1986102787 hasConcept C2775864247 @default.
• W1986102787 hasConcept C2776134451 @default.
• W1986102787 hasConcept C2778034309 @default.
• W1986102787 hasConcept C2778375690 @default.
• W1986102787 hasConcept C2778715236 @default.
• W1986102787 hasConcept C2779419675 @default.
• W1986102787 hasConcept C2780051608 @default.
• W1986102787 hasConcept C2780580376 @default.
• W1986102787 hasConcept C2780733359 @default.
• W1986102787 hasConcept C2780764818 @default.
• W1986102787 hasConcept C2781112942 @default.
• W1986102787 hasConcept C2910564767 @default.
• W1986102787 hasConcept C42219234 @default.
• W1986102787 hasConcept C71924100 @default.
• W1986102787 hasConceptScore W1986102787C118552586 @default.
• W1986102787 hasConceptScore W1986102787C126322002 @default.
• W1986102787 hasConceptScore W1986102787C142724271 @default.
• W1986102787 hasConceptScore W1986102787C15744967 @default.
• W1986102787 hasConceptScore W1986102787C170493617 @default.
• W1986102787 hasConceptScore W1986102787C197934379 @default.
• W1986102787 hasConceptScore W1986102787C204787440 @default.
• W1986102787 hasConceptScore W1986102787C27081682 @default.
• W1986102787 hasConceptScore W1986102787C2775864247 @default.
• W1986102787 hasConceptScore W1986102787C2776134451 @default.
• W1986102787 hasConceptScore W1986102787C2778034309 @default.
• W1986102787 hasConceptScore W1986102787C2778375690 @default.
• W1986102787 hasConceptScore W1986102787C2778715236 @default.
• W1986102787 hasConceptScore W1986102787C2779419675 @default.
• W1986102787 hasConceptScore W1986102787C2780051608 @default.
• W1986102787 hasConceptScore W1986102787C2780580376 @default.

• next